CAPTRUST Financial Advisors’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Sell
50,051
-20,508
-29% -$651K ﹤0.01% 1528
2026
Q1
$2.22M Buy
70,559
+63,501
+900% +$2M ﹤0.01% 1160
2025
Q4
$208K Buy
+7,058
New +$196K ﹤0.01% 2507
2024
Q3
Sell
-19,062
Closed -$565K 2347
2024
Q2
$565K Buy
19,062
+4,068
+27% +$113K ﹤0.01% 1441
2024
Q1
$452K Buy
+14,994
New +$416K ﹤0.01% 1537

Other funds holding RTO

CAPTRUST Financial Advisors's RTO Position: Q2 2026 in Review

CAPTRUST Financial Advisors reduced its Rentokil (RTO) stake by 29% in Q2 2026, selling an estimated $651K and leaving 50,051 shares worth $1.43M. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

CAPTRUST Financial Advisors first reported a position in RTO in Q1 2024 and has held it in 5 quarters since. The position peaked at $2.22M in Q1 2026. 284 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • CAPTRUST Financial Advisors held 50,051 shares of Rentokil worth $1.43M as of Q2 2026.
  • CAPTRUST Financial Advisors sold 20,508 Rentokil shares in Q2 2026, an estimated $651K.
  • Rentokil made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #1528 holding.
  • CAPTRUST Financial Advisors first reported a position in Rentokil in Q1 2024 and has held it in 5 quarters since.
  • CAPTRUST Financial Advisors's Rentokil position peaked at $2.22M in Q1 2026.
  • 284 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.